Author Teunissen, Charlotte E.

1 to 17 of 17 Items

2014 | Journal Article
The influence of genetic variants in SORL1 gene on the manifestation of Alzheimer's disease
Louwersheimer, E.; Ramirez, A.; Cruchaga, C.; Becker, T.; Kornhuber, J. ; Peters, O. & Heilmann, S. et al. (2014)
Neurobiology of Aging, 36(3) pp. 1605.e13-1605.e20. DOI: https://doi.org/10.1016/j.neurobiolaging.2014.12.007
Details DOI

2014 | Journal Article
SUCLG2 identified as both a determinator of CSF Aβ1–42 levels and an attenuator of cognitive decline in Alzheimer's disease
Ramirez, A.; van der Flier, W. M.; Herold, C.; Ramonet, D.; Heilmann, S.; Lewczuk, P. & Popp, J. et al. (2014)
Human Molecular Genetics, 23(24) pp. 6644-6658. DOI: https://doi.org/10.1093/hmg/ddu372
Details DOI

2014 | Journal Article
Biobanking of CSF: International standardization to optimize biomarker development
Teunissen, C. E.; Tumani, H.; Engelborghs, S. & Mollenhauer, B. (2014)
Clinical Biochemistry, 47(4-5) pp. 288-292. DOI: https://doi.org/10.1016/j.clinbiochem.2013.12.024
Details DOI PMID PMC WoS

2015 | Journal Article |
A practical guide to immunoassay method validation
Andreasson, U.; Perret-Liaudet, A.; van Waalwijk van Doorn, L. J. C.; Blennow, K.; Chiasserini, D.; Engelborghs, S. & Fladby, T. et al. (2015)
Frontiers in Neurology, 6 art. UNSP 179. DOI: https://doi.org/10.3389/fneur.2015.00179
Details DOI PMID PMC WoS

2015 | Journal Article |
The central biobank and virtual biobank of BiOMarKaPD: a resource for studies on neurodegenerative diseases
Reijs, B. L. R.; Teunissen, C. E.; Goncharenko, N.; Betsou, F.; Blennow, K.; Baldeiras, I. & Brosseron, F. et al. (2015)
Frontiers in Neurology, 6 art. UNSP 216. DOI: https://doi.org/10.3389/fneur.2015.00216
Details DOI PMID PMC WoS

2016 | Journal Article
Comparison of Different Matrices as Potential Quality Control Samples for Neurochemical Dementia Diagnostics
Lelental, N.; Brandner, S.; Kofanova, O.; Blennow, K.; Zetterberg, H.; Andreasson, U. & Engelborghs, S. et al. (2016)
Journal of Alzheimer's Disease, 52(1) pp. 51-64. DOI: https://doi.org/10.3233/jad-150883
Details DOI

2016 | Journal Article
Multicenter immunoassay validation of cerebrospinal fluid neurofilament light: a biomarker for neurodegeneration
Miller, A.-M.; Rutkowska, A.; Bahl, J. M. C.; Herukka, S.-K.; Koel-Simmelink, M. J. A.; Kruse, N. & Mollenhauer, B. et al. (2016)
Bioanalysis, 8(21) pp. 2243-2254. DOI: https://doi.org/10.4155/bio-2016-0114
Details DOI PMID PMC WoS

2016 | Journal Article
Validation of soluble amyloid-β precursor protein assays as diagnostic CSF biomarkers for neurodegenerative diseases
van Waalwijk van Doorn, L. J. C.; Koel-Simmelink, M. J.; Haußmann, U.; Klafki, H. ; Struyfs, H.; Linning, P. & Knölker, H.-J. et al. (2016)
Journal of Neurochemistry, 137(1) pp. 112-121. DOI: https://doi.org/10.1111/jnc.13527
Details DOI PMID PMC

2016 | Journal Article
Cerebrospinal Fluid Alzheimer's Disease Biomarkers Across the Spectrum of Lewy Body Diseases: Results from a Large Multicenter Cohort
Steenoven, I. van; Aarsland, D.; Weintraub, D.; Londos, E.; Blanc, F.; van der Flier, W. M. & Teunissen, C. E. et al. (2016)
Journal of Alzheimer s Disease, 54(1) pp. 287-295. DOI: https://doi.org/10.3233/JAD-160322
Details DOI PMID PMC WoS

2017 | Journal Article
Detection of contactin-2 in cerebrospinal fluid (CSF) of patients with Alzheimer's disease using Fluorescence Correlation Spectroscopy (FCS)
Chatterjee, M.; Nöding, B.; Willemse, E. A.; Koel-Simmelink, M. J.; van der Flier, W. M.; Schild, D. & Teunissen, C. E. (2017)
Clinical Biochemistry, 50(18) pp. 1061-1066. DOI: https://doi.org/10.1016/j.clinbiochem.2017.08.017
Details DOI

2018 | Journal Article
Cerebrospinal fluid and blood biomarkers for neurodegenerative dementias: An update of the Consensus of the Task Force on Biological Markers in Psychiatry of the World Federation of Societies of Biological Psychiatry
Lewczuk, P. ; Riederer, P.; O’Bryant, S. E.; Verbeek, M. M.; Dubois, B.; Visser, P. J. & Jellinger, K. A. et al. (2018)
The World Journal of Biological Psychiatry, 19(4) pp. 244-328. DOI: https://doi.org/10.1080/15622975.2017.1375556
Details DOI

2018 | Journal Article
Prevalence of the apolipoprotein E ε4 allele in amyloid β positive subjects across the spectrum of Alzheimer's disease
Mattsson, N.; Groot, C.; Jansen, W. J.; Landau, S. M.; Villemagne, V. L.; Engelborghs, S. & Mintun, M. M. et al. (2018)
Alzheimer's & Dementia, 14(7) pp. 913-924. DOI: https://doi.org/10.1016/j.jalz.2018.02.009
Details DOI

2018 | Journal Article |
White paper by the Society for CSF Analysis and Clinical Neurochemistry: Overcoming barriers in biomarker development and clinical translation
Teunissen, C. E.; Otto, M. ; Engelborghs, S.; Herukka, S.-K.; Lehmann, S.; Lewczuk, P. & Lleó, A. et al. (2018)
Alzheimer's Research & Therapy, 10(1). DOI: https://doi.org/10.1186/s13195-018-0359-x
Details DOI

2021 | Journal Article
Preanalytical Stability of CSF Total and Oligomeric Alpha-Synuclein
Abdi, I. Y.; Majbour, N. K.; Willemse, E. A. J.; van de Berg, W. D. J.; Mollenhauer, B. ; Teunissen, C. E. & El-Agnaf, O. M. (2021)
Frontiers in Aging Neuroscience, 13. DOI: https://doi.org/10.3389/fnagi.2021.638718
Details DOI

2021 | Journal Article
Clinical reporting following the quantification of cerebrospinal fluid biomarkers in Alzheimer's disease: An international overview
Delaby, C.; Teunissen, C. E.; Blennow, K.; Alcolea, D.; Arisi, I.; Amar, E. B. & Beaume, A. et al. (2021)
Alzheimer's & Dementia,. DOI: https://doi.org/10.1002/alz.12545
Details DOI

2023 | Journal Article
C1q is increased in cerebrospinal fluid-derived extracellular vesicles in Alzheimer's disease: A multi-cohort proteomics and immuno-assay validation study
Chatterjee, M.; Özdemir, S.; Kunadt, M.; Koel-Simmelink, M.; Boiten, W.; Piepkorn, L. & Pham, T. V. et al. (2023)
Alzheimer's & Dementia: The journal of the Alzheimer's Association,. DOI: https://doi.org/10.1002/alz.13066
Details DOI PMID PMC

Göttingen All

issue date

ASC DESC

10 20 50 100